Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
or

Lannett Company Inc (LCI)

Lannett Company Inc (LCI)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.6855 +0.0255 (+3.86%) 04/19/23 [NYSE]
N/A x N/A N/A x N/A
Post-market 0.6855 unch (unch) -
Quote Overview for Wed, Apr 19th, 2023
Day Low
0.6500
Day High
0.7196
Open 0.6500
Previous Close 0.6600 0.6600
Volume 280,600 280,600
Avg Vol 123,065 123,065
Stochastic %K 2.28% 2.28%
Weighted Alpha -68.87 -68.87
5-Day Change +0.0235 (+3.55%) +0.0235 (+3.55%)
52-Week Range 0.6375 - 3.7200 0.6375 - 3.7200
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 7,381
  • Shares Outstanding, K 10,767
  • Annual Sales, $ 340,580 K
  • Annual Income, $ -231,620 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 0.95
  • Price/Sales 0.02
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -6.44
  • Most Recent Earnings $-1.36 on 02/01/23
  • Next Earnings Date 05/03/23
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Drugs

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/23
See More
  • Average Estimate -1.56
  • Number of Estimates 2
  • High Estimate -1.56
  • Low Estimate -1.56
  • Prior Year -1.64
  • Growth Rate Est. (year over year) +4.88%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.6375 +7.53%
on 04/14/23
Period Open: 1.6500
1.8900 -63.73%
on 04/03/23
-0.9645 (-58.45%)
since 03/17/23
3-Month
0.6375 +7.53%
on 04/14/23
Period Open: 2.5180
3.2500 -78.91%
on 02/07/23
-1.8325 (-72.78%)
since 01/19/23
52-Week
0.6375 +7.53%
on 04/14/23
Period Open: 2.8552
3.7200 -81.57%
on 12/21/22
-2.1697 (-75.99%)
since 04/19/22

Most Recent Stories

More News
LANNETT SHARES UPDATE

/PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) (the "Company") today shared a business update as it focuses on strategically positioning the Company to...

LCI : 0.6855 (+3.86%)
LANNETT REPORTS IMPROVED FISCAL 2023 SECOND QUARTER FINANCIAL RESULTS; RAISES FULL-YEAR GUIDANCE

Q2 Business and Financial Highlights: Net Sales were $80.9 Million Gross Margin was 18%, Adjusted Gross Margin was 19% Net Sales, Gross Margin and Adjusted...

LCI : 0.6855 (+3.86%)
LANNETT ANNOUNCES 1 FOR 4 REVERSE STOCK SPLIT

/PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced that its Board of Directors approved a 1-for-4 reverse stock split of its issued and...

LCI : 0.6855 (+3.86%)
LANNETT TO REPORT FISCAL 2023 SECOND-QUARTER FINANCIAL RESULTS, HOST CONFERENCE CALL ON WEDNESDAY, FEBRUARY 1

/PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced that it will report financial results for its fiscal 2023 second quarter on Wednesday,...

LCI : 0.6855 (+3.86%)
LANNETT PROVIDES DEVELOPMENT UPDATE ON BIOSIMILAR INSULIN PRODUCTS

/PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today provided an update on the clinical advancement and development of its biosimilar insulin aspart and...

LCI : 0.6855 (+3.86%)
LANNETT ANNOUNCES PATENT LICENSES FOR THE PEN INJECTOR DELIVERY DEVICE TO BE USED FOR ITS INSULIN GLARGINE AND INSULIN ASPART DEVELOPMENT PROGRAM

/PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced that it has entered into an agreement with Ypsomed AG, the manufacturer and supplier of the...

LCI : 0.6855 (+3.86%)
LANNETT TO REPORT FISCAL 2023 FIRST-QUARTER FINANCIAL RESULTS, HOST CONFERENCE CALL ON WEDNESDAY, NOVEMBER 2

/PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced that it will report financial results for its fiscal 2023 first quarter on Wednesday,...

LCI : 0.6855 (+3.86%)
LANNETT RECEIVES FDA APPROVAL TO MANUFACTURE NUMBRINO® AT SEYMOUR PLANT

/PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced that it has received approval from the US Food and Drug Administration (FDA) to manufacture...

LCI : 0.6855 (+3.86%)
This Dividend Stock Has 49% Upside, According to Wall Street

Despite fantastic earnings, STAG Industrial is down 42% this year.

STAG : 31.77 (-4.16%)
LCI : 0.6855 (+3.86%)
FDX : 203.61 (-1.90%)
AMZN : 165.87 (-3.90%)
LANNETT ANNOUNCES SUBJECT DOSING COMPLETE FOR PIVOTAL CLINICAL TRIAL OF BIOSIMILAR INSULIN GLARGINE

/PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced that subject dosing has been completed in the pivotal clinical trial of biosimilar insulin...

LCI : 0.6855 (+3.86%)
LANNETT REPORTS FISCAL 2022 FOURTH-QUARTER, FULL-YEAR FINANCIAL RESULTS

Q4 Business and Financial Highlights: Net Sales were $74.2 Million Adjusted Gross Margin Better than Expected, Improved vs Q3 Cash Was $88 Million at June 30...

LCI : 0.6855 (+3.86%)
LANNETT TO REPORT FISCAL 2022 FOURTH-QUARTER, FULL-YEAR FINANCIAL RESULTS, HOST CONFERENCE CALL ON WEDNESDAY, AUGUST 24

/PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced that it will report financial results for its fiscal 2022 fourth quarter and full year on...

LCI : 0.6855 (+3.86%)
Pre-Market Brief: Stock Indexes Fall as Netflix Plunges

Morning Markets March S&P 500 futures this morning tumbled to a 3-month low and are down -0.60%. A -20% plunge in Netflix in pre-market trading is leading technology stocks and the overall market lower...

NFLX : 986.78 (+1.41%)
MARA : 12.41 (-1.97%)
MSTR : 315.06 (-0.67%)
PPG : 99.18 (-0.87%)
CSX : 27.31 (-1.34%)
LLNW : 2.46 (+1.65%)
COIN : 173.77 (-0.72%)
ECL : 230.36 (-3.51%)
LCI : 0.6855 (+3.86%)
RIOT : 6.34 (-1.86%)
BTBT : 1.7600 (-1.12%)
NET : 100.86 (-6.52%)
Lannett To Report Fiscal 2022 First-quarter Financial Results, Host Conference Call On Wednesday, November 3

/PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced that it will report financial results for its fiscal 2022 first quarter on Wednesday,...

LCI : 0.6855 (+3.86%)
LANNETT REPORTS FISCAL 2022 FOURTH-QUARTER, FULL-YEAR FINANCIAL RESULTS

Q4 Business and Financial Highlights: Net Sales were $74.2 Million Adjusted Gross Margin Better than Expected, Improved vs Q3 Cash Was $88 Million at June 30...

LCI : 0.6855 (+3.86%)
LANNETT TO REPORT FISCAL 2022 FOURTH-QUARTER, FULL-YEAR FINANCIAL RESULTS, HOST CONFERENCE CALL ON WEDNESDAY, AUGUST 24

/PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced that it will report financial results for its fiscal 2022 fourth quarter and full year on...

LCI : 0.6855 (+3.86%)
Pre-Market Brief: Stock Indexes Fall as Netflix Plunges

Morning Markets March S&P 500 futures this morning tumbled to a 3-month low and are down -0.60%. A -20% plunge in Netflix in pre-market trading is leading technology stocks and the overall market lower...

NFLX : 986.78 (+1.41%)
MARA : 12.41 (-1.97%)
MSTR : 315.06 (-0.67%)
PPG : 99.18 (-0.87%)
CSX : 27.31 (-1.34%)
LLNW : 2.46 (+1.65%)
COIN : 173.77 (-0.72%)
ECL : 230.36 (-3.51%)
LCI : 0.6855 (+3.86%)
RIOT : 6.34 (-1.86%)
BTBT : 1.7600 (-1.12%)
NET : 100.86 (-6.52%)
Lannett To Report Fiscal 2022 First-quarter Financial Results, Host Conference Call On Wednesday, November 3

/PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced that it will report financial results for its fiscal 2022 first quarter on Wednesday,...

LCI : 0.6855 (+3.86%)

Business Summary

Lannett Company manufactures and distributes high quality affordable generic medications that are the therapeutic equivalent of the brand-name pharmaceuticals. Their portfolio consists of numerous products across a wide range of therapeutic areas. Lannett believes that their ability to select viable...

See More

Key Turning Points

3rd Resistance Point 0.7897
2nd Resistance Point 0.7546
1st Resistance Point 0.7201
Last Price 0.6855
1st Support Level 0.6505
2nd Support Level 0.6154
3rd Support Level 0.5809

See More

52-Week High 3.7200
Fibonacci 61.8% 2.5425
Fibonacci 50% 2.1788
Fibonacci 38.2% 1.8150
Last Price 0.6855
52-Week Low 0.6375

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro